Indeed, echinomycin-treated GPx2 KD tumours showed dramatic reductions in p63 and KRT14 levels, resulting in KRT8-enriched tumours (Fig. 7a, b), indicative of luminal differentiation. This evidence concerns the gene GPX2 and neoplasm.